Atlas Trials

Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis

Clinical trial NCT02132260 · COMPLETED

Trial details

NCT number
NCT02132260
Sponsor
Sun Pharmaceutical Industries, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Tinea Pedis
Start date
2013-08-01
Primary completion
2014-02-01
Enrollment
890

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.